Published in Hospital and Nursing Home Week, April 15th, 2004
BL and DLBCL "account for nearly all pediatric nonlymphoblastic B-cell lymphomas," scientists in the United States explained. "Because clinical behavior, prognosis, and response to therapy might differ, diagnostic accuracy is important."
"Morphologic examination often is sufficient, but occasionally, diagnostic ancillary studies are required," noted M. Frost and colleagues at the University of Utah. "In adults, immunophenotyping is useful; however, pediatric data are limited."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.